compounded tirzepatide fda Crackdown Puts Pressure on GLP-1 Compounders, Telehealth Providers FDA Announces End To Compounded

In this study, participants using semaglutide had a lower risk for CVD-related events when compared with placebo.38 These results build on prior evidence that GLP-1s not only support blood sugar and weight management but also offer significant cardiovascular protection in high-risk populations.39 A 2021 systematic review published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews examined six studies involving over 182,000 adults with T2DM to evaluate the cardioprotective effects of GLP-1s (primarily liraglutide and exenatide) taken in conjunction with blood pressure and cholesterol lowering medications.40 The findings showed consistent improvements in cardiac function, including increased left ventricular ejection fraction40 and reduced heart chamber volume, along with weight loss and improved myocardial blood flow

Because obviously we know, especially some of our older patients, sarcopenia can be a severe problem resulting in balance issues and falls and fractures and you name it, and all kinds of long-term problems

Perrin NE, Davies MJ, Robertson N, Snoek FJ, Khunti K

The study confirmed that metaphit induced high-voltage activity, and synchronized spike on the EEG only 30 minutes after administration

Also known by its generic name semaglutide, the medication regulates hunger signals and allows people to feel full while eating less